This topic contains a solution. Click here to go to the answer

Author Question: When matching is used as a control procedure, assignment of participants to groups is: a. not ... (Read 33 times)

kshipps

  • Hero Member
  • *****
  • Posts: 571
When matching is used as a control procedure, assignment of participants to groups is:
 
  a. not random.
  b. random.
  c. counterbalanced.
  d. controlled.

Question 2

In a matched-subjects procedure, participants are matched on a variable that:
 
  a. is highly correlated with the independent variable.
  b. is highly correlated with the dependent variable.
  c. is uncorrelated with the dependent variable.
  d. is not confounding.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ankilker

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

B

Answer to Question 2

A




kshipps

  • Member
  • Posts: 571
Reply 2 on: Jun 20, 2018
YES! Correct, THANKS for helping me on my review


ktidd

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library